RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Opiant Pharmaceuticals Employees 2024

Opiant Pharmaceuticals Employees

21

Opiant Pharmaceuticals Dividend yield

Ticker

OPNT

ISIN

US6837501039

WKN

A2AFQ6

In 2024, Opiant Pharmaceuticals employed 21 people, a 0% change from the 0 number of employees in the previous year.

Opiant Pharmaceuticals Aktienanalyse

What does Opiant Pharmaceuticals do?

Opiant Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of medications for the treatment of addiction disorders and acute medical needs. The company was founded in 2006 and is headquartered in Santa Monica, California. Since its inception, Opiant Pharmaceuticals Inc. has developed innovative drugs that can help mitigate the effects of addiction disorders and meet the demand for emergency medications. The company follows a clear business model based on the implementation of clinical trials and the commercialization of the resulting medications. One of Opiant Pharmaceuticals Inc.'s core areas is the development of medications that can be used in the context of opioid overdoses. One of the best-known products is Narcan Nasal Spray, an emergency medication that can be used in cases of opioid overdose. The product is fast, easy, and safe to use and has proven to be highly effective in practice. In addition to the development of medications for the treatment of opioid overdoses, Opiant Pharmaceuticals Inc. has also developed medications for the treatment of alcohol dependence. One of the best-known medications is Nalmefene, sold as Selincro in Europe and Canada. The medication is used in combination with behavioral counseling and has proven to be an effective treatment option for patients with alcohol dependence. Another division of Opiant Pharmaceuticals Inc. is the development of medications for acute medical needs. This includes medications such as Fentanyl Nasal Spray, which can be used for the treatment of acute pain. Another medication is the opioid analgesic Oxycodone combined with Naltrexone, which is used for the treatment of moderate to severe pain. In addition, Opiant Pharmaceuticals Inc. also has a wide range of products in the pipeline that are in various stages of development and clinical trials. These include medications for the treatment of methamphetamine and cocaine dependence, as well as for postoperative nausea and vomiting. The company actively invests in research and development and is constantly striving to develop innovative and effective medications that can help minimize the effects of addiction disorders and meet medical needs. Overall, Opiant Pharmaceuticals Inc. has established itself as a leading provider of medications for the treatment of addiction disorders. The company has an impressive track record in drug development and aims to offer effective treatment options to patients around the world. With a strong pipeline of products and a dedicated leadership team, Opiant Pharmaceuticals Inc. is well-positioned to continue growing in the coming years and establish itself as a leading provider of medications for the treatment of addiction disorders. Opiant Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Opiant Pharmaceuticals's Employee Base

Opiant Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Opiant Pharmaceuticals's operational capacity and future potential.

Year-to-Year Comparison

Assessing Opiant Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Opiant Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Opiant Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Opiant Pharmaceuticals Stock

How many employees does Opiant Pharmaceuticals have this year?

Opiant Pharmaceuticals has 21 undefined employees this year.

How many employees did Opiant Pharmaceuticals have compared to the previous year?

Compared to the previous year, Opiant Pharmaceuticals had 0% more employees.

What impact did the number of employees have on the company Opiant Pharmaceuticals?

The number of employees has a direct impact on the efficiency and productivity of Opiant Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Opiant Pharmaceuticals?

The number of employees can also have an impact on investors of Opiant Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Opiant Pharmaceuticals affect the company?

An increase in equity of Opiant Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Opiant Pharmaceuticals's equity affect the company?

A reduction in equity of Opiant Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Opiant Pharmaceuticals?

Some factors that can influence the equity of Opiant Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Opiant Pharmaceuticals so important for investors?

The equity of Opiant Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Opiant Pharmaceuticals influence the company?

The number of employees at Opiant Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Opiant Pharmaceuticals evolved in recent years?

In recent years, the number of employees at Opiant Pharmaceuticals has changed by NaN.

How many employees does Opiant Pharmaceuticals currently have?

Opiant Pharmaceuticals currently has 21 undefined employees.

Why is the number of employees important for investors of Opiant Pharmaceuticals?

The number of employees is important for investors of Opiant Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Opiant Pharmaceuticals take to change the number of employees?

To change the number of employees, Opiant Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Opiant Pharmaceuticals pay?

Over the past 12 months, Opiant Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Opiant Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Opiant Pharmaceuticals?

The current dividend yield of Opiant Pharmaceuticals is .

When does Opiant Pharmaceuticals pay dividends?

Opiant Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Opiant Pharmaceuticals?

Opiant Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Opiant Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Opiant Pharmaceuticals located?

Opiant Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Opiant Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Opiant Pharmaceuticals from 5/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/7/2024.

When did Opiant Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/7/2024.

What was the dividend of Opiant Pharmaceuticals in the year 2023?

In the year 2023, Opiant Pharmaceuticals distributed 0 USD as dividends.

In which currency does Opiant Pharmaceuticals pay out the dividend?

The dividends of Opiant Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Opiant Pharmaceuticals

Our stock analysis for Opiant Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Opiant Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.